Other languages Evolent Health, Inc.

Equities

EVH

US30050B1017

Real-time Estimate Cboe BZX Other stock markets 01:05:56 2024-05-08 pm EDT			5-day change	1st Jan Change
27.16 ^USD	-1.65%		-0.44%	-17.80%

Apr. 22	Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target	MT
Mar. 28	Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Evolent Health Q4 Adjusted Income, Revenue Rise; Q1, 2024 Revenue Guidance Set; Shares Jump After Hours	Feb. 22
Evolent Health, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2024 and Full Year Ending December 31, 2024	Feb. 22
Evolent Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 22
Evolent Health, Inc. Announces Board Changes	Feb. 14
Evolent Health Plans $350 Million Convertible Senior Notes Offering; Shares Fall	Dec. 05
Evolent Health, Inc. Provides Earnings Guidance for the Fourth Quarter Ending December 31, 2023 and Full Year 2023	Nov. 02
Evolent Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02
Insider Sell: Evolent Health	23-08-17
Evolent Health, Inc. Provides Earnings Guidance for the Third Quarter Ending September 30, 2023 and Reiterates Earnings Guidance for the Full Year Ending December 31, 2023	23-08-02
Evolent Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-02
Evolent Health, Inc. Appoints Toyin Ajayi to Its Board of Directors	23-07-26
Evolent Health to Rebrand as Evolent	23-07-11
Insider Sell: Evolent Health	23-06-30
Insider Sell: Evolent Health	23-06-20
Insider Sell: Evolent Health	23-06-05
Evolent Health Q1 Adjusted Earnings, Revenue Rise	23-05-04
Evolent Health, Inc. Announces Executive Changes	23-05-03
Evolent Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-03
Evolent Health, Inc. Provides Revenue Guidance for the Second Quarter Ending June 30, 2023 and for the Year Ending December 31, 2023	23-05-03
Evolent Health, Inc. Announces Board Changes	23-04-19

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Evolent Health, Inc.

Equities

EVH

US30050B1017

Other languages

Filters